IGI Logo

Glenmark Pharmaceuticals is currently trading at Rs. 1943.00, up by 20.05 points or 1.04% from its previous closing of Rs. 1922.95 on the BSE.

The scrip opened at Rs. 1922.05 and has touched a high and low of Rs. 1949.75 and Rs. 1901.80 respectively. So far 7640 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 2286.15 on 11-Jul-2025 and a 52 week low of Rs. 1274.70 on 28-Feb-2025.

Last one week high and low of the scrip stood at Rs. 2041.50 and Rs. 1901.80 respectively. The current market cap of the company is Rs. 55022.10 crore.

The promoters holding in the company stood at 46.65%, while Institutions and Non-Institutions held 38.30% and 15.06% respectively. 

Glenmark Pharmaceuticals has made the remaining investment of Rs 0.24 crore in O2 Renewable Energy XXIV. Pursuant to this, the company now holds 32.95% stake in O2 Renewable Energy XXIV. 

Earlier, the company had invested Rs 1.75 crore through Equity and Compulsory Convertible Debentures out of the total agreed investment of an amount not exceeding Rs 1.99 crore.

Glenmark Pharmaceuticals is a global research-led pharmaceutical company with presence across Generics, Specialty and OTC business with operations in over 50 countries.